CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 90 filers reported holding CUREVAC N V in Q1 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $161,411 | +15.6% | 23,158 | 0.0% | 0.00% | – |
| Q4 2022 | $139,642 | -23.3% | 23,158 | 0.0% | 0.00% | – |
| Q3 2022 | $182,000 | -42.2% | 23,158 | 0.0% | 0.00% | – |
| Q2 2022 | $315,000 | -46.7% | 23,158 | -23.1% | 0.00% | – |
| Q1 2022 | $591,000 | -42.7% | 30,133 | +0.2% | 0.00% | – |
| Q4 2021 | $1,032,000 | -36.6% | 30,059 | +0.8% | 0.00% | -100.0% |
| Q3 2021 | $1,628,000 | -28.4% | 29,810 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $2,273,000 | -37.5% | 30,970 | -22.1% | 0.00% | 0.0% |
| Q1 2021 | $3,636,000 | – | 39,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |